{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:38:17Z","timestamp":1777624697696,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00535-016-1200-6","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T16:33:38Z","timestamp":1459269218000},"page":"1141-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Ipragliflozin, a sodium\u2013glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long\u2013Evans Tokushima fatty rats"],"prefix":"10.1007","volume":"51","author":[{"given":"Norihisa","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuteru","family":"Kitade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Namisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"Douhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Kawaratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"issue":"Suppl 1","key":"1200_CR1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2014from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38\u201353.","journal-title":"J Hepatol"},{"issue":"6","key":"1200_CR2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"issue":"4","key":"1200_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-014-0057-8","volume":"2","author":"K Iwaisako","year":"2014","unstructured":"Iwaisako K, Taura K, Koyama Y, et al. Strategies to detect hepatic myofibroblasts in liver cirrhosis of different etiologies. Curr Pathobiol Rep. 2014;2(4):209\u201315.","journal-title":"Curr Pathobiol Rep"},{"issue":"16","key":"1200_CR4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221\u201331.","journal-title":"N Engl J Med"},{"issue":"3","key":"1200_CR5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","volume":"30","author":"KG Tolman","year":"2007","unstructured":"Tolman KG, Fonseca V, Dalpiaz A, et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30(3):734\u201343.","journal-title":"Diabetes Care"},{"issue":"5","key":"1200_CR6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","volume":"42","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987\u20131000.","journal-title":"Hepatology"},{"issue":"12 Suppl 2","key":"1200_CR7","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0026-0495(78)80007-9","volume":"27","author":"CR Kahn","year":"1978","unstructured":"Kahn CR. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978;27(12 Suppl 2):1893\u2013902.","journal-title":"Metabolism"},{"issue":"2","key":"1200_CR8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","volume":"133","author":"A Gastaldelli","year":"2007","unstructured":"Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133(2):496\u2013506.","journal-title":"Gastroenterology"},{"issue":"2","key":"1200_CR9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","volume":"29","author":"AL Mason","year":"1999","unstructured":"Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29(2):328\u201333.","journal-title":"Hepatology"},{"issue":"3","key":"1200_CR10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","volume":"126","author":"Y Shintani","year":"2004","unstructured":"Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004;126(3):840\u20138.","journal-title":"Gastroenterology"},{"issue":"6","key":"1200_CR11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","volume":"21","author":"ME Allison","year":"1994","unstructured":"Allison ME, Wreghitt T, Palmer CR, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994;21(6):1135\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"1200_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","volume":"35","author":"S Chitturi","year":"2002","unstructured":"Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35(2):373\u20139.","journal-title":"Hepatology"},{"issue":"5","key":"1200_CR13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1478-3231.2005.01130.x","volume":"25","author":"R Sugimoto","year":"2005","unstructured":"Sugimoto R, Enjoji M, Kohjima M, et al. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation ofmitogen-activated protein kinase. Liver Int. 2005;25(5):1018\u201326.","journal-title":"Liver Int"},{"issue":"6","key":"1200_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hep.510290632","volume":"29","author":"G Svegliati-Baroni","year":"1999","unstructured":"Svegliati-Baroni G, Ridolfi F, Di Sario A, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology. 1999;29(6):1743\u201351.","journal-title":"Hepatology"},{"issue":"4","key":"1200_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756283X11403809","volume":"4","author":"LB Wagner Van","year":"2011","unstructured":"Van Wagner LB, Rinella ME. The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. Therap Adv Gastroenterol. 2011;4(4):249\u201363.","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"1200_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1572-0241.2001.03553.x","volume":"96","author":"SH Caldwell","year":"2001","unstructured":"Caldwell SH, Hespenheide EE, Redick JA, et al. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol. 2001;96(2):519\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1200_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1464-5491.2009.02894.x","volume":"27","author":"JE Gerich","year":"2010","unstructured":"Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;27(2):136\u201342.","journal-title":"Diabet Med"},{"key":"1200_CR18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ki.2010.509","volume":"120","author":"A Mather","year":"2011","unstructured":"Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;120:S1\u20136.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"1200_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneph.2010.38","volume":"6","author":"A Mather","year":"2010","unstructured":"Mather A, Pollock C. Renal glucose transporters: novel targets for hyperglycemia management. Nat Rev Nephrol. 2010;6(5):307\u201311.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1200_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116972","volume":"93","author":"Y Kanai","year":"1994","unstructured":"Kanai Y, Lee WS, You G, et al. The human kidney low affinity Na+\/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for d-glucose. J Clin Invest. 1994;93(1):397\u2013404.","journal-title":"J Clin Invest"},{"issue":"1","key":"1200_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pharmthera.2013.04.003","volume":"139","author":"E Kurosaki","year":"2013","unstructured":"Kurosaki E, Ogasawara H. Ipragliflozin and other sodium glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data. Pharmacol Ther. 2013;139(1):51\u20139.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1200_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/dom.12331","volume":"17","author":"A Kashiwagi","year":"2015","unstructured":"Kashiwagi A, Kazuta K, Goto K, et al. Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study. Diabetes Obes Metab. 2015;17(3):304\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"1200_CR23","doi-asserted-by":"crossref","unstructured":"Watanabe Y, Nakayama K, Taniuchi N, et al. Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes. PLoS One. 2015;10(1):e0116851.","DOI":"10.1371\/journal.pone.0116851"},{"issue":"7","key":"1200_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DMSO.S58786","volume":"1","author":"SP Vickers","year":"2014","unstructured":"Vickers SP, Cheetham SC, Headland KR, et al. Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet. Diabetes Metab Syndr Obes. 2014;1(7):265\u201375.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1200_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1507\/endocrj.EJ14-0335","volume":"62","author":"M Takahara","year":"2015","unstructured":"Takahara M, Shiraiwa T, Matsuoka TA, et al. Ameliorated pancreatic \u03b2 cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin. Endocr J. 2015;62(1):77\u201386.","journal-title":"Endocr J"},{"key":"1200_CR26","doi-asserted-by":"crossref","unstructured":"Hayashizaki-Someya Y, Kurosaki E, Takasu T, et al. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. Eur J Pharmacol. 2015;5(754):19\u201324.","DOI":"10.1016\/j.ejphar.2015.02.009"},{"issue":"4","key":"1200_CR27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1053\/j.gastro.2009.06.045","volume":"137","author":"Y Kodama","year":"2009","unstructured":"Kodama Y, Kisseleva T, Iwaisako K, et al. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology. 2009;137(4):1467\u201377.","journal-title":"Gastroenterology"},{"issue":"1","key":"1200_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139(1):323\u201334.","journal-title":"Gastroenterology"},{"issue":"9","key":"1200_CR29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/BF00402172","volume":"38","author":"T Sato","year":"1995","unstructured":"Sato T, Asahi Y, Toide K, et al. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima fatty rat, a new model of NIDDM. Diabetologia. 1995;38(9):1033\u201341.","journal-title":"Diabetologia"},{"issue":"7","key":"1200_CR30","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 1","key":"1200_CR31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji H, Kuriyama S, Yoshii J, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 2001;34(4 Pt 1):745\u201350.","journal-title":"Hepatology"},{"issue":"5","key":"1200_CR32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.510300509","volume":"30","author":"H Yoshiji","year":"1999","unstructured":"Yoshiji H, Kuriyama S, Hicklin DJ, et al. KDR\/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology. 1999;30(5):1179\u201386.","journal-title":"Hepatology"},{"key":"1200_CR33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","volume":"49","author":"K Kaji","year":"2014","unstructured":"Kaji K, Yoshiji H, Ikenaka Y, et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol. 2014;49:481\u201391.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1200_CR34","first-page":"801","volume":"22","author":"K Kaji","year":"2008","unstructured":"Kaji K, Yoshiji H, Kitade M, et al. Impact of insulin resistance on the progression of chronic liver diseases. Int J Mol Med. 2008;22(6):801\u201343.","journal-title":"Int J Mol Med."},{"issue":"1","key":"1200_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/jsre.1998.5553","volume":"83","author":"SA Spector","year":"1999","unstructured":"Spector SA, Olson ET, Gumbs AA, et al. Human insulin receptor and insulin signaling proteins in hepatic disease. J Surg Res. 1999;83(1):32\u20135.","journal-title":"J Surg Res"},{"key":"1200_CR36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.510230423","volume":"4","author":"E Bhunchet","year":"1996","unstructured":"Bhunchet E, Eishi Y, Wake K. Contribution of immune response to the hepatic fibrosis induced by porcine serum. Hepatology. 1996;4:811\u20137.","journal-title":"Hepatology"},{"issue":"11","key":"1200_CR37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/gut.2003.031997","volume":"53","author":"A Galli","year":"2004","unstructured":"Galli A, Ceni E, Crabb DW, et al. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPAR-gamma independent mechanisms. Gut. 2004;53(11):1688\u201397.","journal-title":"Gut"},{"issue":"1","key":"1200_CR38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","volume":"132","author":"T Ota","year":"2007","unstructured":"Ota T, Takamura T, Kurita S, et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology. 2007;132(1):282\u201393.","journal-title":"Gastroenterology"},{"issue":"5","key":"1200_CR39","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","volume":"15","author":"W Peverill","year":"2014","unstructured":"Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15(5):8591\u2013638.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1200_CR40","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1038\/nutd.2014.20","volume":"7","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Takeda M, et al. Tofogliflozin, a sodium\/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models. Nutr Diabetes. 2014;7(4):e125.","journal-title":"Nutr Diabetes"},{"issue":"3","key":"1200_CR41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/db09-1907","volume":"60","author":"AG Oliveira","year":"2011","unstructured":"Oliveira AG, Carvalho BM, Tobar N, et al. Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes. 2011;60(3):784\u201396.","journal-title":"Diabetes"},{"issue":"12","key":"1200_CR42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12986-015-0028-z","volume":"6","author":"X Gao","year":"2015","unstructured":"Gao X, Yan D, Zhao Y, et al. Moderate calorie restriction to achieve normal weight reverses \u03b2-cell dysfunction in diet-induced obese mice: involvement of autophagy. Nutr Metab (Lond). 2015;6(12):34.","journal-title":"Nutr Metab (Lond)"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1200-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1200-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1200-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1200-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:18Z","timestamp":1559083218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1200-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1200-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}